Else Marie Agger

Title: Innovations of Else Marie Agger in Immunological Diagnostics

Introduction

Else Marie Agger is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of immunological diagnostics, particularly in the detection of tuberculosis. With a total of three patents to his name, Agger's work has the potential to enhance diagnostic methods and improve patient outcomes.

Latest Patents

Agger's latest patents include innovative diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis. This invention discloses methods with enhanced specificity and sensitivity for detecting tuberculosis, offering a significant advancement over previous diagnostic mixtures. Another notable patent involves the use of monomycolyl glycerol (MMG) as an adjuvant. This discovery identifies MMG and its derivatives as highly bioactive lipids capable of stimulating human dendritic cells at low doses. The implications of this research extend to the development of new adjuvants for vaccines against infectious diseases and disorders such as Alzheimer's disease.

Career Highlights

Else Marie Agger is affiliated with the Statens Serum Institut, where he continues to advance research in immunology. His work has garnered attention for its potential applications in both diagnostics and therapeutic interventions.

Collaborations

Agger collaborates with notable colleagues, including Peter Andersen and Ida Rosenkrands, to further his research initiatives. Their combined expertise contributes to the innovative projects at the Statens Serum Institut.

Conclusion

Else Marie Agger's contributions to immunological diagnostics and his innovative patents position him as a key figure in the field. His work not only enhances the detection of tuberculosis but also opens new avenues for vaccine development and treatment strategies.